Evidence map›Paper›PMID 35517439›Full record

ArticleRSC advances2020

Lanthanide complexes based on a new bis-chelating carbacylamidophosphate (CAPh) scorpionate-like ligand.

Iryna Olyshevets, Vladimir Ovchynnikov, Nataliia Kariaka, Viktoriya Dyakonenko, Svitlana Shishkina, Tatiana Sliva, Małgorzata Ostrowska, Aleksandra Jedyńczuk, Elżbieta Gumienna-Kontecka, Vladimir Amirkhanov

Abstract read
In one paragraph

Article in RSC advances, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Iryna OlyshevetsTaras Shevchenko National University of Kyiv, Department of Chemistry 64/13, Volodymyrska Street Kyiv 01601 Ukraine olishevetsirina@gmail.com.ORCID https://orcid.org/0000-0002-2936-7602
Vladimir OvchynnikovTaras Shevchenko National University of Kyiv, Department of Chemistry 64/13, Volodymyrska Street Kyiv 01601 Ukraine olishevetsirina@gmail.com.
Nataliia KariakaTaras Shevchenko National University of Kyiv, Department of Chemistry 64/13, Volodymyrska Street Kyiv 01601 Ukraine olishevetsirina@gmail.com.
Viktoriya DyakonenkoInstitute for Single Crystals, National Academy of Science of Ukraine Nauky ave. 60 Kharkiv 61001 Ukraine.
Svitlana ShishkinaInstitute for Single Crystals, National Academy of Science of Ukraine Nauky ave. 60 Kharkiv 61001 Ukraine.ORCID https://orcid.org/0000-0002-3946-1061
Tatiana SlivaTaras Shevchenko National University of Kyiv, Department of Chemistry 64/13, Volodymyrska Street Kyiv 01601 Ukraine olishevetsirina@gmail.com.
Małgorzata OstrowskaFaculty of Chemistry, University of Wroclaw F. Joliot-Curie 14 Wroclaw 50383 Poland.
Aleksandra JedyńczukFaculty of Chemistry, University of Wroclaw F. Joliot-Curie 14 Wroclaw 50383 Poland.ORCID https://orcid.org/0000-0001-5047-2434
Elżbieta Gumienna-KonteckaFaculty of Chemistry, University of Wroclaw F. Joliot-Curie 14 Wroclaw 50383 Poland.ORCID https://orcid.org/0000-0002-9556-6378
Vladimir AmirkhanovTaras Shevchenko National University of Kyiv, Department of Chemistry 64/13, Volodymyrska Street Kyiv 01601 Ukraine olishevetsirina@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The novel bis-chelating carbacylamidophosphate type ligand, tetramethyl[pyridine-2,6-diyldi(iminocarbonyl)]diamidophosphate (H

Identifiers

PMID35517439
PMCPMC9055167

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.